Catalyst Pharmaceuticals, Inc.

FL · United States · Reporting entity ID 100000481813

Total reported 2019–2025

$5.50M

#675 of 2,960 reporting companies — 0% of all reported industry payments

$2.84M in general payments across 21,416 records, plus $2.65M in research funding across 189 records.

How it breaks down

General payments $2,844,866

Research funding $2,654,638

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.